Phathom Pharmaceuticals, Inc. generated $175.1M in revenue in fiscal year 2025. This represents an increase of 216.9% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $274.9M in revenue. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Phathom Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PHAT Revenue by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
PHAT Revenue by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Phathom Pharmaceuticals, Inc. financials
Frequently Asked Questions
Phathom Pharmaceuticals, Inc. generated $175.1M in revenue in fiscal year 2025.
Phathom Pharmaceuticals, Inc. (PHAT) revenue rose by 216.9% year over year, from $55.3M to $175.1M in fiscal year 2025.
Phathom Pharmaceuticals, Inc. (PHAT) reported $274.9M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Phathom Pharmaceuticals, Inc. (PHAT) reported $84.7M in revenue in Q3 2026. This represents an increase of 71.1% from the same quarter a year earlier.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Phathom Pharmaceuticals, Inc. (PHAT) reported on that line in every period on record.